(Q63613262)

English

Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment

clinical trial

Statements

A 3-arm, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients With Walking Impairment (English)
0 references
0 references
0 references
29 March 2018
0 references
1 September 2019
0 references
540
0 references
18 year
0 references
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit